BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9234384)

  • 1. Mucin-producing adenocarcinoma of the lung, with special reference to goblet cell type adenocarcinoma: immunohistochemical observation and Ki-ras gene mutation.
    Maeshima A; Miyagi A; Hirai T; Nakajima T
    Pathol Int; 1997 Jul; 47(7):454-60. PubMed ID: 9234384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed mucinous-type and non-mucinous-type adenocarcinoma of the lung: immunohistochemical examination and K- ras gene mutation.
    Maeshima A; Sakamoto M; Hirohashi S
    Virchows Arch; 2002 Jun; 440(6):598-603. PubMed ID: 12070599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary signet-ring cell carcinoma of the lung: histochemical and immunohistochemical characterization.
    Hayashi H; Kitamura H; Nakatani Y; Inayama Y; Ito T; Kitamura H
    Hum Pathol; 1999 Apr; 30(4):378-83. PubMed ID: 10208457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression.
    Rossi G; Murer B; Cavazza A; Losi L; Natali P; Marchioni A; Migaldi M; Capitanio G; Brambilla E
    Am J Surg Pathol; 2004 Apr; 28(4):442-52. PubMed ID: 15087663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas.
    Yatabe Y; Koga T; Mitsudomi T; Takahashi T
    J Pathol; 2004 Jun; 203(2):645-52. PubMed ID: 15141379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Napsin-A, TTF-1, EGFR, and ALK Status Determination in Lung Primary and Metastatic Mucin-Producing Adenocarcinomas.
    Rossi G; Cavazza A; Righi L; Sartori G; Bisagni A; Longo L; Pelosi G; Papotti M
    Int J Surg Pathol; 2014 Aug; 22(5):401-7. PubMed ID: 24651909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HNF4α as a marker for invasive mucinous adenocarcinoma of the lung.
    Sugano M; Nagasaka T; Sasaki E; Murakami Y; Hosoda W; Hida T; Mitsudomi T; Yatabe Y
    Am J Surg Pathol; 2013 Feb; 37(2):211-8. PubMed ID: 23108025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs.
    Tsuchiya E; Furuta R; Wada N; Nakagawa K; Ishikawa Y; Kawabuchi B; Nakamura Y; Sugano H
    J Cancer Res Clin Oncol; 1995; 121(9-10):577-81. PubMed ID: 7559740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goblet cell carcinoid of the appendix: a specific type of carcinoma.
    van Eeden S; Offerhaus GJ; Hart AA; Boerrigter L; Nederlof PM; Porter E; van Velthuysen ML
    Histopathology; 2007 Dec; 51(6):763-73. PubMed ID: 18042066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
    Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
    J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of point mutation in c-Ki-ras oncogene in lung adenocarcinoma with particular reference to cytologic subtypes.
    Kobayashi T; Tsuda H; Noguchi M; Hirohashi S; Shimosato Y; Goya T; Hayata Y
    Cancer; 1990 Jul; 66(2):289-94. PubMed ID: 2196110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study.
    Wu J; Chu PG; Jiang Z; Lau SK
    Am J Clin Pathol; 2013 Feb; 139(2):160-6. PubMed ID: 23355200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appendiceal goblet cell carcinoids and adenocarcinomas ex-goblet cell carcinoid are genetically distinct from primary colorectal-type adenocarcinoma of the appendix.
    Jesinghaus M; Konukiewitz B; Foersch S; Stenzinger A; Steiger K; Muckenhuber A; Groß C; Mollenhauer M; Roth W; Detlefsen S; Weichert W; Klöppel G; Pfarr N; Schlitter AM
    Mod Pathol; 2018 May; 31(5):829-839. PubMed ID: 29327707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. K-ras gene point mutation in neogenetic lesions of subpleural fibrotic lesions: either an early genetic event in lung cancer development or a non-specific genetic change during the inflammatory reparative process.
    Maeshima AM; Maeshima A; Kawashima O; Nakajima T
    Pathol Int; 1999 May; 49(5):411-8. PubMed ID: 10417684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
    Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
    Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
    Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
    J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification].
    Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of ras oncogene activation in lung carcinomas in Hong Kong.
    Lung ML; Wong M; Lam WK; Lau KS; Kwan S; Fu KH; Cheung H; Yew WW
    Cancer; 1992 Aug; 70(4):760-3. PubMed ID: 1322782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
    Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
    Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features.
    Finberg KE; Sequist LV; Joshi VA; Muzikansky A; Miller JM; Han M; Beheshti J; Chirieac LR; Mark EJ; Iafrate AJ
    J Mol Diagn; 2007 Jul; 9(3):320-6. PubMed ID: 17591931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.